WHO ICTRP trial

Poly-unsaturated fats for improving nasal polyps and asthma

ISRCTN99085436 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN99085436
Public title Poly-unsaturated fats for improving nasal polyps and asthma
Scientific title The efficacy and mechanisms of action of n-3 poly-unsaturated fatty acid supplementation in people with non-steroidal exacerbated airways disease and uncontrolled asthma
Primary sponsor Norfolk and Norwich University Hospitals NHS Foundation Trust
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Interventional
Phase Phase III
Countries United Kingdom;England
Conditions Non-steroidal exacerbated respiratory disease and uncontrolled asthma Respiratory
Interventions Randomisation will be performed centrally and generated by a secure web-based system on a 1:1 basis with stratification for recruiting site and inclusion into the sputum subgroup. Patients will be randomised to receive either of the…
Registration date May 9, 2023
Target size 98
Secondary IDs 2021-003641-38;Nil known;173-12-20, IRAS 1004006, CPMS 56101
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations